News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,591 Results
Type
Article (87800)
Company Profile (824)
Press Release (778951)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233184)
Career Advice (4144)
Deals (39844)
Drug Delivery (144)
Drug Development (91373)
Employer Resources (203)
FDA (18365)
Job Trends (17415)
News (397750)
Policy (39953)
Tag
Academia (3006)
Academic (2)
Accelerated approval (30)
Adcomms (35)
Allergies (136)
Alliances (56981)
ALS (174)
Alzheimer's disease (1765)
Antibody-drug conjugate (ADC) (315)
Approvals (18515)
Artificial intelligence (583)
Autoimmune disease (140)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (195)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (632)
Cancer (4772)
Cardiovascular disease (417)
Career advice (3566)
Career pathing (40)
CAR-T (294)
CDC (59)
Celiac Disease (1)
Cell therapy (794)
Cervical cancer (37)
Clinical research (76670)
Collaboration (1632)
Company closure (5)
Compensation (1089)
Complete response letters (65)
COVID-19 (2983)
CRISPR (94)
C-suite (753)
Cystic fibrosis (148)
Data (5941)
Decentralized trials (2)
Denatured (69)
Depression (133)
Diabetes (502)
Diagnostics (7180)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (279)
Drug pricing (208)
Drug shortages (36)
Duchenne muscular dystrophy (228)
Earnings (99910)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134604)
Executive appointments (1011)
FDA (21311)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1455)
Gene editing (205)
Generative AI (60)
Gene therapy (636)
GLP-1 (1093)
Government (5429)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (56)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (278)
Immuno-oncology (44)
Indications (79)
Infectious disease (3258)
Inflammatory bowel disease (199)
Inflation Reduction Act (16)
Influenza (115)
Intellectual property (224)
Interviews (816)
IPO (17946)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10155)
Liver cancer (95)
Longevity (14)
Lung cancer (655)
Lymphoma (367)
Machine learning (40)
Management (66)
Manufacturing (767)
MASH (168)
Medical device (14978)
Medtech (15019)
Mergers & acquisitions (22898)
Metabolic disorders (1312)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (327)
Neuropsychiatric disorders (87)
Neuroscience (2987)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (629)
Opinion (327)
Ovarian cancer (156)
Pain (194)
Pancreatic cancer (210)
Parkinson's disease (278)
Partnered (36)
Patents (475)
Patient recruitment (428)
Peanut (59)
People (66676)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23678)
Phase II (33267)
Phase III (25088)
Pipeline (4099)
Policy (323)
Postmarket research (3554)
Preclinical (10671)
Press Release (72)
Prostate cancer (233)
Psychedelics (53)
Radiopharmaceuticals (292)
Rare diseases (826)
Real estate (7437)
Recruiting (80)
Regulatory (28674)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (152)
Series A (244)
Series B (179)
Service/supplier (30)
Sickle cell disease (101)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (97)
The Weekly (117)
Vaccines (1114)
Venture capital (82)
Weight loss (440)
Women's health (79)
Worklife (21)
Date
Last 7 days (237)
Last 30 days (2140)
Last 365 days (33212)
2025 (33130)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (328)
Arkansas (14)
Asia (51386)
Australia (9025)
California (10929)
Canada (3195)
China (1080)
Colorado (461)
Connecticut (484)
Delaware (330)
Europe (118071)
Florida (1599)
Georgia (354)
Hawaii (3)
Idaho (68)
Illinois (906)
India (62)
Indiana (527)
Iowa (22)
Japan (400)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1402)
Massachusetts (8096)
Michigan (344)
Minnesota (636)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (118)
New Hampshire (81)
New Jersey (2978)
New Mexico (32)
New York (2918)
North Carolina (1544)
North Dakota (10)
Northern California (5163)
Ohio (332)
Oklahoma (22)
Oregon (52)
Pennsylvania (2213)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4200)
Tennessee (169)
Texas (1725)
United States (39740)
Utah (327)
Vermont (1)
Virginia (275)
Washington D.C. (85)
Washington State (923)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,591 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
China’s First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent’s TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
December 25, 2025
·
11 min read
Press Releases
Modalis Announces Publication in Human Gene Therapy of Study Demonstrating Efficient LAMA1 Gene Activation for the Treatment of LAMA2-CMD
December 25, 2025
·
3 min read
Press Releases
Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
December 25, 2025
·
6 min read
Press Releases
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
December 25, 2025
·
17 min read
Press Releases
PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
December 25, 2025
·
2 min read
Press Releases
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
December 25, 2025
·
8 min read
Press Releases
Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study
December 25, 2025
·
4 min read
Press Releases
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
December 25, 2025
·
5 min read
Press Releases
Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy
December 25, 2025
·
11 min read
Press Releases
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 25, 2025
·
6 min read
1 of 86,760
Next
